HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lauder Bumble & Bumble Purchase Extends High-End Hair Care Portfolio

This article was originally published in The Rose Sheet

Executive Summary

Estee Lauder's newly acquired majority interest in salon hair care company Bumble & bumble expands the company's salon presence into the top-tier market. Terms of the agreement, announced June 2, were not disclosed.

You may also be interested in...



Graham Webb/Bumble And Bumble Acquisition Deal Never Definitive - Lauder

Graham Webb's lawsuit against Estee Lauder should be dismissed as the salon hair care manufacturer "never reached a definite and final contract" to acquire Bumble and bumble, Estee Lauder says in a March 21 memorandum filed in St. Paul, Minn. federal court.

Graham Webb/Bumble And Bumble Acquisition Deal Never Definitive - Lauder

Graham Webb's lawsuit against Estee Lauder should be dismissed as the salon hair care manufacturer "never reached a definite and final contract" to acquire Bumble and bumble, Estee Lauder says in a March 21 memorandum filed in St. Paul, Minn. federal court.

Clinique, Aveda Growth Lead 97% Jump In Lauder Hair Care Sales

Estee Lauder hair care sales soared 97% to $45.6 mil. in the fiscal first quarter ended Sept. 30, President and CEO Fred Langhammer reported during an analyst conference call Oct. 24. The impressive category growth largely is attributable to the "excellent" July debut of Clinique Simple Hair Care System.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008073

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel